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Alopecia areata (AA) is a complex autoimmune disease characterized by 
round or oval patches of non-scarring hair loss that is mediated by 
lymphocytes affecting the hair follicles. To treat localized AA, 
intralesional corticosteroid injections and topical corticosteroids are 
most commonly used, while for widespread AA, systemic steroids, 
immunosuppresants, and contact immunotherapy are commonly 
considered. However, therapeutic options for refractory AA that is 
unresponsive to these conventional treatments are limited. Various 
lasers have been suggested in recent studies to treat AA. The effect of 
308-nm excimer laser was the most studied, while others, including 
neodymium-doped yttrium aluminum garnet, erbium:glass laser, 
fractional CO2 laser, and low-level laser therapy, have also been 
assessed. Despite the nascent state of research on lasers as a treatment 
option for AA, there have been a great deal of promising results. It is 
possible for lasers to become the mainstay treatment option of AA.
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InTroDucTIon 
Alopecia areata (AA) is a complex autoimmune disease 
characterized by round or oval patches of non-scarring 
hair loss, which is mediated by lymphocytes that affects 
the hair follicles.1 The development of hair loss involves 
aberrant modulation of the hair growth cycle, resulting 
in dystrophic anagen hair shedding and/or increased 
telogen state follicles.2,3 The management of AA varies 
widely among dermatologists. Intralesional corticosteroid 
injections and topical corticosteroids are most commonly 
used, while topical minoxidil and topical immunotherapy 
are also treatment options generally considered.4,5 The 
treatment of refractory AA is generally considered dif-
ficult and mostly ineffective, which eventually lead to the 
recent studies with the use of targeted therapies.6,7 No 
treatments, however, have been shown to have long-term 
benefit compared to placebo.4
The use of lasers as another treatment option for AA 
began not long ago, with the observation of “paradoxical 
hypertrichosis,” which was initially used to describe para-
doxical hair growth in patients treated for photoepilation 
with intense pulsed light therapy.8 Since then, additional 
cases of paradoxical hypertrichosis have been reported, 
which was found to occur possibly in low fluences and all 
types of lasers.9 Studies have tried to investigate the un-
derlying mechanisms, in which low fluence of heat caus-
ing sub-therapeutic injury was thought to induce follicular 
stem cell proliferation and differentiation by increasing 
the level of heat shock proteins and other factors, which 
may play a role in regulation of cell growth and differen-
tiation.10,11
The basis for the use of laser had also been supported 
by the finding of hair growth stimulation in the process of 
wound healing.12 Hair follicles have been found to develop 
anew after wounding, via activation of Wnt-mediated 
signaling pathway. Conversely, cutaneous wound heal-
ing also substantially accelerates during anagen stage of 
hair cycle.13 Ultimately, laser treatment has been shown 
to induce hair regrowth by induction and prolongation of 
anagen through Wnt/β-catenin pathway in the murine 
model,14 providing evidences of the use of lasers in AA. In 
addition, because AA is known as an autoimmune disor-
der,15 lasers that may induce immunomodulatory effects, 
such as 308-nm excimer laser,16 has also been suggested 
for the treatment of AA.
The exact mechanisms of the therapeutic effects of la-
sers on AA are still unknown, yet studies on the use of la-
sers in the treatment of AA have been steadily increased. 
Although not widely used compared to other treatment 
modalities, various laser therapies had shown therapeutic 
efficacy and their use as another option for the treatment 
of refractory AA have been suggested.17
308-nM EXcIMEr LASEr
Excimer laser consists of xenon and chloride that emits 
its total energy at a wavelength of 308 nm, which lies 
within the UVB spectrum.18,19 The pathophysiology under-
lying excimer lasers that induce the therapeutic effects in 
AA are thought to be different from that of other lasers. 
Although the exact mechanism is unclear, excimer laser 
is thought to induce apoptosis of T cells, thereby leading 
to therapeutic effects in inflammatory diseases, such as 
psoriasis.16 With the discovery of AA as an autoimmune 
disorder with T cell-mediated inflammation of the hair 
follicle,15 the use of excimer lasers has been suggested. 
Since the benefit of the excimer laser on AA first reported 
by Gundogan et al.,20 numerous studies have confirmed 
its efficacy.21-23
The largest study so far was done on 18 patients with 
recalcitrant AA that involved the scalp, beard, arms and 
legs. Each alopecic patch was treated twice a week for a 
maximum of 24 sessions. Hair regrowth has been shown 
in 41.5% of the patches, whereas no growth of hair was 
observed in the control patches,22 confirming the efficacy 
of the treatment. Another study has been done on 11 chil-
dren with recalcitrant AA of the scalp, in which regrowth 
was noted in 60% of patches treated with the excimer 
laser for 12 weeks versus no regrowth in untreated con-
trol patches,24 suggesting that excimer lasers are safe 
and effective not only in adults with refractory AA, but in 
children as well. Recently, a comparative study was done 
by dividing a single alopecic patch into control and treated 
side and applying the excimer laser for 12 weeks, twice 
a week.25 The diameter of the hair was found to be sig-
nificantly increased in the treated area when compared 
with the control side. Based on the results of the efficacy 
in treating refractory AA in these studies, the results sug-
gest excimer laser as another option for the treatment of 
AA.
The protocols of excimer laser therapy used were gen-
erally consistent in the studies, in which the initial dose 
was 50 mJ/cm2 less than the minimal erythema dose and 
the doses were then increased by 50 mJ/cm2 every two 
session for usually every week, since the treatments were 
usually done twice a week.22,25 Excimer laser is a device 
widely used in the field of dermatology and has been con-
sidered to be relatively safe, with possible adverse events 
of burn, persistent erythema and pain.25 In these studies, 
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excimer laser treatment on AA was generally mild and 
tolerable, even in children,24 in which the adverse events 
were mild, including erythema, hyperpigmentation, itch-
ing, and mild peeling of the skin.22
Although all studies have reported the efficacy of ex-
cimer laser in AA, the therapeutic results seem to be poor 
in patients with alopecia universalis and alopecia totalis,21 
in which no hair regrowth was observed in patches on the 
extremities.22 Also, atopic diathesis had been found to a 
poor prognostic factor, as patients with atopic diseases 
had shown minimal responses to the therapy.22 Based 
on these findings, excimer laser can be a safe and effec-
tive therapeutic method for refractory AA confined to the 
scalp. The sample sizes of the previous studies, however, 
were small, in which large-scale clinical trials are needed 
to confirm the efficacy and safety of excimer lasers in the 
treatment of patients with AA.
FrAcTIonAL non-ABLATIVE 
PHoToTHErMoLYSIS LASEr
Stimulation of hair growth during the wound healing 
process is another finding that can be the basis of laser 
treatment in hair regrowth12. Fractional non-ablative pho-
tothermolysis is a laser technique that produces columns 
of “microthermal treatment zones (MTZs)” that extend 
down to the reticular dermis, sparing the surrounding 
tissues, and as a result, does not damage the stratum 
corneum.26 As a result, wound-healing process would be 
induced, which would hypothetically cause hair growth. 
The efficacy of fractional non-ablative photothermolysis 
laser was first observed in a report of a 35-year-old male 
with 2-year history of recalcitrant AA,27 who was non-
responsive to treatments with topical corticosteroids, in-
tralesional corticosteroid injections, and topical minoxidil. 
The patient was treated with fractional erbium glass laser 
weekly for 24 weeks with a pulse energy of 10-15 mJ, a 
density of 300 MTZ/cm2/pass, and two passes per ses-
sion. Hair growth was noted after 1 month and complete 
regrowth was achieved at 6 months, with no hair loss in 
the 6-month follow-up period. A recent study has also 
reported the efficacy of erbium glass laser in five patients 
with AA.28 The patients were treated for 2 to 3 sessions, 
with an interval of 3-6 weeks and the parameters of flu-
ences ranging from 30-45 mJ/cm2, 6-8 density and 8-10 
passes. All patients obtained fully or almost fully regrowth 
at 3 months, without any side effects except for minimal 
pain during the treatment.28
The possible mechanisms hypothesized for fractional 
photothermolysis laser in hair regrowth are the induc-
tion of T-cell apoptosis and direct enhancement of hair 
growth.27 In addition, the therapeutic effects of the laser 
have been proven in larger number of patients with an-
drogenic alopecia,29,30 but since the exact mechanisms of 
hair regrowth is unknown, the elucidation of the patho-
physiology is necessary. Although the efficacy has been 
observed in few cases, further studies with larger sample 
sizes are needed to suggest fractional photothermolysis 
laser as a possible therapeutic option for AA in the future. 
LASErS uSED To IncrEASE DruG DELIVErY 
Studies have assessed the usefulness of laser therapies 
in increasing the delivery of the topical medications used 
in AA.31,32 Efficient topical drug delivery may be challeng-
ing due to the barrier function of the stratum corneum 
and laser treatment can precisely and selectively remove 
the stratum corneum in a controlled and noncontact 
manner.33 A study was performed on nude mouse and 
porcine skin to evaluate whether erbium:yttrium alumi-
num garnet (erbium:YAG) laser may facilitate the perme-
ability of topical medications used in alopecia. The appli-
cation of the laser at an ablation depth of 6 and 10 μm was 
found to increase the skin accumulation of minoxidil two-
fold to ninefold, depending on the selected skin barriers.32 
A similar clinical study was performed in five patients with 
AA by using either radiofrequency (RF) or fractional CO2 
lasers followed by topical application of triamcinolone, in 
addition to the application of acoustic pressure wave ul-
trasound afterwards. Complete recovery was observed in 
all patients with one to six sessions of treatment, depend-
ing on the clinical responses.31 Besides the ablative effect 
of removing the stratum corneum, the laser may interact 
with sebum to break up the barrier function, increasing 
the skin delivery of drugs. The minimally invasive, well-
controlled approach of laser-mediated drug permeation 
may offer a potential way to treat alopecia.32
LoW-LEVEL LASEr THErAPY
The idea of low-level laser therapy (LLLT) for the treat-
ment of hair loss began in 1967 with the observation of 
increased hair growth while investigating whether cancer 
can be induced by low-powered ruby laser therapy (694 
nm). LLLT was applied on to the shaved skin of mice, in 
which faster hair regrowth was observed when compared 
to the untreated mice.34 Several recent studies have then 
evaluated the efficacy of LLLT in the treatment of different 
types of hair loss, especially in androgenetic alopecia, in 
which the data have shown promising results.35
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HairMax LaserComb (Lexington International, Boca Ra-
ton, FL, USA), a 655-nm LLLT device, which is approved 
by the FDA to treat androgenetic alopecia,36 was used to 
assessed the efficacy in a C3H/HeJ mouse model of AA 
induced by heat.10 After treatment of 20 seconds daily, 
three times per week for a total of 6 weeks, hair regrowth 
was observed in the mice in the treated group compared 
to no growth in the untreated group, with increased num-
ber of anagen hair follicles in the treated group.10 A simi-
lar study of LaserComb used in spontaneous and graft-
induced AA in C3H/HeJ mice, however, did not induce 
hair growth with the similar protocols,37 in which further 
studies are needed to settle the controversies. 
Several clinical studies of LLLT have been done on an-
drogenic alopecia with favorable outcomes,38 whereas the 
number of clinical studies in AA is limited. A study in 2006 
has reported the effectiveness of low-level pulsed infrared 
diode laser (904 nm) in the treatment of 16 patients with 
34 AA patches non-responsive to conventional treatment 
modalities.39 The patients received four treatments on a 
weekly basis, for a total of one month, with parameters of 
04/s, 1.2 mW. The success rate was reported to be very 
high with regrowth observed in 94% of the patches, while 
no regrowth was seen in the control patches.39 A similar 
study was recently performed with pulsed infrared diode 
laser on 23 patients with 52 AA patches resistant to con-
ventional treatment modalities.40 Favorable outcomes 
were also observed, in which significant hair regrowth 
was seen in the treated patches compared to the control 
patches. Lastly, although technically not a laser, another 
study was done with linear polarized infrared light with 
frequencies of 600-1600 nm irradiated on 15 patients 
with AA for 3 minutes once every one or two weeks.41 Of 
the irradiated areas, 46.7% had shown hair regrowth 1.6 
months earlier in the irradiated areas than in the non-
irradiated areas.
The exact mechanisms of LLLT is unknown, yet it is 
assumed to stimulate anagen re-entry in telogen hair fol-
licles, prolong duration of anagen phase, increase rates 
of proliferation in active anagen hair follicles and to pre-
vent premature catagen development.10,36 The number of 
studies are scarce and the mechanisms are needed to be 
elucidated, but with further larger studies in the future, 
LLLT may be considered as a treatment option.
MIScELLAnEouS LASErS
Recently, a study has been conducted to evaluate the 
efficacy of two different lasers, neodymium-doped:yttrium 
aluminum garnet (Nd:YAG) and fractional CO2 laser, in Ta
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the treatment of patients with refractory AA.42 Thirty-
two patients were recruited and three different alopecic 
patches were selected in each patients, where Nd:YAG 
laser was applied to one of the patches, fractional CO2 la-
ser to the second patch, and the remaining patch was set 
as the control. The Nd:YAG laser was used with a pulse 
duration of 30 milliseconds and an energy of 10 J/cm2, 
whereas the fractional CO2 laser was applied with a pow-
er of 30 W, 120 mm probe diameter, pulse energy range 
of 10-45 mJ/cm2 and density range of 75-100 spot/cm2/
pass. The Severity of Alopecia Tool (SALT) score was used 
for assessment, which was found to be improved in 22% 
of the patients and no statistically difference was found in 
the mean hair count of the three different patches in each 
patients.42 The use of the two lasers were not effective in 
the study, and the need for larger studies with different 
parameters of the lasers for the treatment of AA has been 
suggested.
concLuSIon
Although some poor prognostic factors are known in 
AA, the course of the disease is generally unpredictable 
and the treatment response can be variable.3 Numerous 
treatment options are available and studies have found 
that up to 50% of patients will recover within 1 year even 
without treatment,43 but possible therapeutic options in 
refractory AA are limited and the efficacies are contro-
versial.4,43 Studies of the use of lasers in the treatment 
of AA have increased recently, and although some of the 
outcomes had been variable, most of the results had 
shown favorable therapeutic outcomes,17 as summarized 
in Table 1.
The pathophysiology of the lasers that take effect 
on hair regrowth in AA is still largely unknown and the 
mechanisms are thought to be different among the 
types of lasers. Excimer lasers have been studied the 
most, which is thought to cause hair regrowth by induc-
ing apoptosis of T cells,19 as AA is known to be a T cell 
mediated disorder.15 Other lasers that have been studied 
include erbium glass laser, Nd: YAG laser, fractional CO2 
laser, and LLLT, which have used based on the findings of 
paradoxical hypertrichosis and hair growth upon wound 
healing.9,12 In addition, some lasers have been used in 
order to increase the skin permeability of drugs used in 
alopecia.31,32 Because the sample size of the studies was 
small, further randomized clinical trials on larger number 
of patients are needed. The Korean national insurance 
does not cover for the use of lasers in the treatment of 
AA, hence limiting its uses in Korea. Thus, the verification 
of the efficacy through further studies may provide in-
creased opportunities for the patients to receive these la-
ser treatments in the future. Despite the limitation in the 
uses and the variability of the mechanisms of the different 
laser devices, most of the studies have shown satisfactory 
results, in which the use of lasers can be suggested as 
another therapeutic option in the treatment of AA.
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